Our data is supported by evidence from a recent proteomic study that showed higher circulating PDE5A levels contributed to a weighted composite score, which predicted incident Alzheimer’s disease and memory deterioration in the Framingham Heart Study Offspring cohort [43]. Here, PDE5A is linked to early-onset autosomal dominant Alzheimer disease.